Literature DB >> 2882006

Salivary secretion of paracetamol in man.

F Kamali, J R Fry, G D Bell.   

Abstract

Plasma and saliva paracetamol levels were measured by HPLC in ten healthy volunteers who took a therapeutic dose after an overnight fast. Salivary levels of the drug were consistently and significantly higher than those in plasma for the first 50 min after oral ingestion, but saliva and plasma levels correlated closely during the elimination phase. There was a highly significant correlation between the AUC 0-alpha calculated from saliva and plasma paracetamol concentration-time curves. The elevated saliva/plasma ratio for the first 50 min was not due to loss of paracetamol from plasma during sample preparation, binding to plasma protein or adsorption to the buccal mucosa. Administration of probenecid in an attempt to block possible active secretion of paracetamol into saliva did not significantly alter the saliva/plasma concentration ratio for the first 50 min, but did significantly reduce this ratio in the time period 125-360 min. The experimental data conformed to a recently proposed model in which elevated saliva/plasma ratios during the early stages following oral ingestion were related to ongoing absorption into the arterial system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882006     DOI: 10.1111/j.2042-7158.1987.tb06967.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  The effect of pirenzepine on gastric emptying and salivary flow rate: constraints on the use of saliva paracetamol concentrations for the determination of paracetamol pharmacokinetics.

Authors:  F Kamali; C Edwards; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.

Authors:  M Brunner; A Schmiedberger; R Schmid; D Jäger; E Piegler; H G Eichler; M Müller
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

3.  Correlation of paired toxic plasma and saliva paracetamol concentrations following deliberate self-poisoning with paracetamol.

Authors:  Jessamine H Soderstrom; Daniel M Fatovich; Christine Mandelt; Sam Vasikaran; David L McCoubrie; Frank F Daly; Sally A Burrows
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.

Authors:  Sam Boase; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

5.  Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man.

Authors:  R E Galinsky; E B Nelson; D E Rollins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Paracetamol elimination in patients with non-insulin dependent diabetes mellitus.

Authors:  F Kamali; S H Thomas; R E Ferner
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.